<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31086" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Ventricular Fibrillation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ludhwani</surname>
            <given-names>Dipesh</given-names>
          </name>
          <aff>Rosalind Franklin University</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Goyal</surname>
            <given-names>Amandeep</given-names>
          </name>
          <aff>University of Kansas Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Jagtap</surname>
            <given-names>Mandar</given-names>
          </name>
          <aff>Magnolia Regional Health Center</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Dipesh Ludhwani declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amandeep Goyal declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mandar Jagtap declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31086.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Arrhythmias originating from the ventricular myocardium or His-Purkinje system are grouped under ventricular arrhythmia (VA). This includes a subset of arrhythmias such as ventricular tachycardia (VT), ventricular fibrillation (VF), premature ventricular contractions (PVC), and ventricular flutter. Wide complex tachycardia (WCT) is used to define all tachyarrhythmia with QRS complex duration greater than 0.12 seconds. VF is a WCT caused by irregular electrical activity and characterized by a ventricular rate of usually greater than 300 with discrete QRS complexes on the electrocardiogram (ECG). This activity reviews the causes, pathophysiology, and presentation of VF and highlights the role of the interprofessional team in its management.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the causes of VF.</p></list-item><list-item><p>Recall the pathophysiology of VF.</p></list-item><list-item><p>Summarize the treatment options for VF.</p></list-item><list-item><p>Review the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected with VF.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31086&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31086">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31086.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Arrhythmias originating from the ventricular myocardium or His-Purkinje system are grouped under ventricular arrhythmia (VA). This includes a subset of arrhythmias such as ventricular tachycardia (VT), ventricular fibrillation (VF), premature ventricular contractions (PVC), and ventricular flutter.&#x000a0;Wide&#x000a0;complex tachycardia&#x000a0;(WCT) is&#x000a0;used to define all tachyarrhythmia with QRS complex duration greater than 0.12 seconds. VF is a WCT caused by irregular electrical activity and characterized by a ventricular rate of usually greater than 300 with discrete QRS complexes on the electrocardiogram (ECG). QRS morphology in VF varies in shape, amplitude, and duration with a&#x000a0;prominent irregular rhythm.<xref ref-type="bibr" rid="article-31086.r1">[1]</xref>&#x000a0;VF is&#x000a0;an extremely&#x000a0;dangerous rhythm significantly compromising cardiac output and ultimately leading to sudden cardiac death (SCD).</p>
        <p>VF has been identified in nearly 70% of cardiac arrest patients. Without treatment, the condition is fatal within minutes. The rates of survival for VF patients outside the hospitals have increased slightly but many continue to have residual anoxic brain damage and neurological deficits.</p>
      </sec>
      <sec id="article-31086.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>VF is often linked to underlying structural heart disease. Three percent to 12% of cases of myocardial infarction (MI) develop VF during the acute phase.<xref ref-type="bibr" rid="article-31086.r2">[2]</xref>&#x000a0;MI patients with complete coronary occlusion on an angiogram, anterior wall infarction, atrial fibrillation, and pre-infarction angina are more prone to develop VF.<xref ref-type="bibr" rid="article-31086.r3">[3]</xref>&#x000a0;Many common conditions associated with VF include electrolyte abnormalities (hypokalemia/hyperkalemia, hypomagnesemia), acidosis, hypothermia, hypoxia, cardiomyopathies, family history of sudden cardiac death, congenital QT abnormalities, Brugada syndrome, and alcohol use. Patients with a&#x000a0;history of VA especially sustained monomorphic or polymorphic VT may transition to VF in susceptible patients.<xref ref-type="bibr" rid="article-31086.r4">[4]</xref>&#x000a0;Genetic predisposition to VF is now increasingly recognized. The first genome-wide association was reported in the AGNES study identifying susceptibility locus for VF at 21q21.<xref ref-type="bibr" rid="article-31086.r5">[5]</xref></p>
      </sec>
      <sec id="article-31086.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>In 2017 the American Heart Association (AHA) update estimated the total annual burden of Out of Hospital Cardiac Arrest (OHCA) at 356,500.&#x000a0; At least 23% of OHCA treated by Emergency Medical Service (EMS) have VF/VT as the initial rhythm. With more than 60% of cardiovascular deaths resulting from cardiac arrest, it remains the leading cause of death worldwide.<xref ref-type="bibr" rid="article-31086.r6">[6]</xref>&#x000a0;Modern advances in assistive devices such as implantable cardioverter-defibrillator (ICD) have had a significant impact on these numbers. Many studies have identified VF as the most common underlying arrhythmia in patients with SCD. Among&#x000a0;patients hospitalized with acute MI, 5% to 10% have VF or VT, and another 5% will have VF or VT within 48 hours of admission.<xref ref-type="bibr" rid="article-31086.r7">[7]</xref>&#x000a0;The true incidence of VF is underestimated, as individuals who suffer OHCA are not covered in most of these studies. Based on Resuscitation Outcomes Consortium (ROC) data, survival to hospital discharge for VF patients was 31.4%.</p>
      </sec>
      <sec id="article-31086.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>VF occurs when parts of ventricular myocardium depolarize erratically in an uncoordinated manner. VF results from&#x000a0;the following:</p>
        <p>
<bold>
<italic toggle="yes">Abnormal Impulse Formation</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Increased automaticity:</italic> Purkinje cells around ischemic areas during MI can initiate ventricular tachycardia.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Triggered activity:</italic> Early and late after depolarization can overcome refractory threshold and generate triggered potential causing extrasystoles.</p>
          </list-item>
        </list>
        <p>
<bold>
<italic toggle="yes">Impulse Conduction</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Functional and anatomical reentry circuits help sustain ventricular arrhythmia.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31086.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>The most common presentation for VF is sudden collapse from cardiac arrest leading to SCD. This results from improper ventricular contraction resulting in low cardiac output. Patients may demonstrate signs of acute MI such as chest pain, shortness of breath, nausea, and&#x000a0;vomiting before the event. Patients with a known history of coronary artery disease or congestive heart failure may show a worsening of chronic symptoms such as angina, dyspnea, orthopnea, paroxysmal nocturnal dyspnea, and pedal edema. At the time of presentation, patients are unconscious, unresponsive, and have no palpable pulse. Without prompt&#x000a0;action, this leads to death within the next few minutes. Patients with ICD for primary or secondary prevention can experience shock from ICD firing at the time of&#x000a0;experiencing VF.</p>
      </sec>
      <sec id="article-31086.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Acute presentation of symptoms and ECG findings lead to the diagnosis.</p>
        <p>
<bold>
<italic toggle="yes">ECG Findings</italic>
</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Fibrillation waves of varying amplitude and shape.</p>
          </list-item>
          <list-item>
            <p>No identifiable P waves, QRS complexes, or T waves</p>
          </list-item>
          <list-item>
            <p>Heart rate anywhere between 150 to 500 per minute</p>
          </list-item>
        </list>
        <p><italic toggle="yes">VF storm:</italic>&#x000a0;Identified by 3 or more episodes of VF or appropriate&#x000a0;shocks from ICD within 24 hours</p>
        <p>Patients surviving VF should have a thorough history and physical examination. A family&#x000a0;history of unexplained cardiac death should be noted. Physicians should review c the patient's cardiac history and the medication list for arrhythmogenic drugs closely. They should also look for and correct reversible causes of VF such as electrolyte abnormalities, acidosis, and hypoxia. The healthcare professional should also evaluate patients for underlying ischemic heart disease with an echocardiogram and emergency angiogram. Of all OHCA, more than 50% have significant coronary artery disease on angiogram.<xref ref-type="bibr" rid="article-31086.r8">[8]</xref></p>
        <p>Appropriate laboratory studies include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Serum electrolytes</p>
          </list-item>
          <list-item>
            <p>Arterial blood gas</p>
          </list-item>
          <list-item>
            <p>Complete blood cell count</p>
          </list-item>
          <list-item>
            <p>Cardiac enzymes</p>
          </list-item>
          <list-item>
            <p>Levels of drugs</p>
          </list-item>
          <list-item>
            <p>Toxicology screen</p>
          </list-item>
          <list-item>
            <p>BNP levels</p>
          </list-item>
        </list>
        <p>The ECG may reveal:</p>
        <list list-type="bullet">
          <list-item>
            <p>MI</p>
          </list-item>
          <list-item>
            <p>Brugada syndrome</p>
          </list-item>
          <list-item>
            <p>Long or short QT interval</p>
          </list-item>
          <list-item>
            <p>WPW</p>
          </list-item>
          <list-item>
            <p>Digitalis toxicity</p>
          </list-item>
          <list-item>
            <p>Epsilon sign (arrhythmogenic right ventricular cardiomyopathy)</p>
          </list-item>
        </list>
        <p>ECHO is usually done to assess the wall motion, ejection fraction and any valvular problems. In addition, Echo will identify any pericardial fluid that may have resulted from CPR.</p>
        <p>EPS is done after the patient is stable to differentiate patients with inducible VF from those with noninducible VF. Patients with induced monomorphic ventricular arrhythmias may be candidates for an ICD.</p>
      </sec>
      <sec id="article-31086.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>
<bold>Acute Management</bold>
</p>
        <p>Due to the high mortality rate and extreme acuity of the condition, VF patients warrant immediate attention. Healthcare professionals should immediately initiate guideline-directed management as per Advanced Cardiac Life Support (ACLS) protocol. There is a lower likelihood of survival if the healthcare professional deviates from the ACLS guidelines.<xref ref-type="bibr" rid="article-31086.r9">[9]</xref>&#x000a0;All patients with cardiac arrest should have an initial assessment while receiving quality CPR. Pulseless VT and VF are both shockable rhythm, and once the staff identifies the rhythm as VF, patients should be shocked immediately with 120 to 200 joules on a biphasic defibrillator or 360 joules using a monophasic. Patients receiving prompt defibrillation have shown improved survival (39.3%) compared to patients in whom defibrillation was delayed by 2 minutes or more (22.2%).<xref ref-type="bibr" rid="article-31086.r10">[10]</xref>&#x000a0;Administer epinephrine and amiodarone as per ACLS protocol in patients sustaining VF rhythm regardless of receiving 3 shocks. Amiodarone significantly improves survival to hospital admission without affecting survival to hospital discharge.<xref ref-type="bibr" rid="article-31086.r11">[11]</xref>&#x000a0;Identifying and addressing the cause of inciting event is equally important. Professionals should undertake cause-specific measures such as securing the airway, correcting electrolytes, administrating fluids, decompressing pneumothorax, draining tamponade while resuscitating the patient. Once the patient attains return of spontaneous circulation (ROSC), physicians should begin a&#x000a0;definitive evaluation for coronary artery disease.</p>
        <p>
<bold>Preventative Management</bold>
</p>
        <p>Primary prevention has been a significant factor in reducing VF-related SCDs. Most VF transition from VT and other VA and hence identifying such arrhythmias at an early stage can help prevent VF. In patients with symptoms suspected to be related to VA, detection using ambulatory electrocardiography and implanted cardiac monitors is recommended. <xref ref-type="bibr" rid="article-31086.r7">[7]</xref>. Healthcare professionals should&#x000a0;offer family members of patients with inherited arrhythmia syndromes genetic testing and counseling for risk stratification.</p>
        <p>
<bold>
<italic toggle="yes">Medication Therapy</italic>
</bold>
</p>
        <p>Amiodarone is the most commonly studied antiarrhythmic for prevention of SCD. The overall effect of amiodarone on survival is controversial. Most studies have failed to show any added benefit when compared to placebo or ICD.<xref ref-type="bibr" rid="article-31086.r12">[12]</xref>&#x000a0;Sotalol, on the other hand, is associated with an&#x000a0;increased risk of mortality by decreasing the defibrillation threshold. A meta-analysis published in 2007 showed a significant reduction in risk of SCD with statin treatment.<xref ref-type="bibr" rid="article-31086.r13">[13]</xref>&#x000a0;Lower&#x000a0;SCD incidence has been reported in patients on chronic beta-blocker therapy for heart failure with reduced ejection fraction.</p>
        <p>
<bold>
<italic toggle="yes">Defibrillators</italic>
</bold>
</p>
        <p>Randomized control trials such as MADIT-I (Multicenter Automated Defibrillator Implantation Trial), MADIT-II, SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial) have clearly&#x000a0;demonstrated mortality benefits with ICD when compared to standard medical therapy. Trials comparing ICD with antiarrhythmic therapy such as AVID (Antiarrhythmic Versus Implantable Defibrillator) have shown similar results.</p>
        <p>ICD placement is recommended for primary prevention of SCD in patients at increased risk of life-threatening VF/VT. ICD placement is also indicated for secondary prevention of SCD in patients with prior episodes of VF and sustained VT.</p>
      </sec>
      <sec id="article-31086.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>It is important to differentiate VF from pulseless electrical activity (PEA)/asystole as both these conditions are managed differently as per ACLS protocol. Other causes of sudden collapse such as aortic dissection and pulmonary embolism&#x000a0;should be considered. The following conditions can be easily confused with VF on an ECG and should be ruled out.</p>
        <list list-type="bullet">
          <list-item>
            <p>Polymorphic ventricular tachycardia</p>
          </list-item>
          <list-item>
            <p>Torsade de pointes</p>
          </list-item>
          <list-item>
            <p>Ventricular flutter</p>
          </list-item>
          <list-item>
            <p>Pulseless electrical activity</p>
          </list-item>
          <list-item>
            <p>Accelerated idioventricular rhythm</p>
          </list-item>
          <list-item>
            <p>SVT with aberrancy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31086.s10" sec-type="Staging">
        <title>Staging</title>
        <p>
<bold>Types of VF on ECG</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Coarse VF:</italic> Majority of the waveforms measure 3 mm or greater</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Fine VF:</italic> Majority of the waveforms measure less than 3 mm</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31086.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis of VF depends on the time from onset to early intervention and defibrillation. Shorter delays are associated with survival rates as high as 50%.<xref ref-type="bibr" rid="article-31086.r14">[14]</xref>&#x000a0;In patients with ST-elevation MI, early VF (fewer than 24 hours) is associated with increased mortality compared to late VF (longer than 24 hours).<xref ref-type="bibr" rid="article-31086.r15">[15]</xref></p>
        <p>VF outside the hospital can be reversed as today there are defibrillators available in many places. But the success of reversal declines at a rate of 5-10% for every minute that is delayed. Even under ideal circumstances, 30-40% of patients survive but many also develop residual neurological deficits because of anoxia. Full recovery is rare.</p>
      </sec>
      <sec id="article-31086.s12" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Anoxic brain injury</p>
          </list-item>
          <list-item>
            <p>Post defibrillation arrhythmias</p>
          </list-item>
          <list-item>
            <p>Injuries from CPR and resuscitation</p>
          </list-item>
          <list-item>
            <p>Skin burns</p>
          </list-item>
          <list-item>
            <p>Long terms disabilities</p>
          </list-item>
          <list-item>
            <p>Myocardial injury</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31086.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>Consultations should include cardiology,&#x000a0;electrophysiology, and interventional cardiology.</p>
      </sec>
      <sec id="article-31086.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Cardiac arrest is a near-death experience impacting not only the patient but family members too.&#x000a0;A variety of health care professionals&#x000a0;should be involved from the onset of arrest up&#x000a0;to hospital discharge. Studies have&#x000a0;continuously&#x000a0;demonstrated the importance of Interprofessional communication and teamwork while resuscitating patients.&#x000a0;Successful resuscitation is an outcome of good communication and understanding your responsibilities. (LOE-1) Physicians, nurses, pharmacists, laboratory technicians all come together and commit to the success of the team.</p>
        <p>Post-resuscitation care brings further contributions from consultants such as a cardiologist, electrophysiologists, and neurologists. These patients need close monitoring by the nurses as recurrence of VF is high. In addition, the patient should be assessed for complications like aspiration, CPR related injuries, renal failure, and brain anoxic damage</p>
        <p>Unfortunately, mortality associated with VF/SCA remains high. Involving family in every step of management is pivotal as it helps in providing a holistic picture. Seeking help from chapel when deciding about goals of care can help the family make difficult decisions. Mild hypothermia has been shown to improve outcomes and should be considered. The patient needs to be seen by the neurologist to assess brain activity, dietitian to assess feeding, nephrologist as renal failure is common, and the pulmonologist to ensure that no aspiration has occurred during resuscitation. The entire team should communicate with each other to ensure that the patient is receiving the optimal standard of care.</p>
        <p>Outcomes</p>
        <p>Patient outcomes can be improved by spreading awareness about the condition and by identifying patients at risk. The outcome of cardiac arrest and subsequently VF depends on time from the arrest to first intervention. Educating the general population about the basics of resuscitation can help avoid delay in treatment and improve patient outcomes especially in OHCA. Identifying and establishing roles amongst various team members can improve outcomes among In-hospital cardiac arrest (IHCA). Mock drills to assess for preparedness can help enhance the quality of resuscitation efforts.</p>
      </sec>
      <sec id="article-31086.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31086&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31086">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/ventricular-fibrillation/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31086">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31086/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31086">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-31086.s16">
        <fig id="article-31086.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Ventricular fibrillation Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="venfib" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-31086.s17">
        <fig id="article-31086.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Ventricular fibrillation Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="venfib" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-31086.s18">
        <title>References</title>
        <ref id="article-31086.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <collab>American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology)</collab>
              <name>
                <surname>Buxton</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Calkins</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Callans</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>DiMarco</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Fisher</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Greene</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Haines</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Hayes</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Heidenreich</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Poppas</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Prystowsky</surname>
                <given-names>EN</given-names>
              </name>
              <name>
                <surname>Schoenfeld</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Zimetbaum</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Goff</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>FL</given-names>
              </name>
              <name>
                <surname>Malenka</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Peterson</surname>
                <given-names>ED</given-names>
              </name>
              <name>
                <surname>Radford</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Redberg</surname>
                <given-names>RF</given-names>
              </name>
            </person-group>
            <article-title>ACC/AHA/HRS 2006 key data elements and definitions for electrophysiological studies and procedures: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (ACC/AHA/HRS Writing Committee to Develop Data Standards on Electrophysiology).</article-title>
            <source>Circulation</source>
            <year>2006</year>
            <month>Dec</month>
            <day>05</day>
            <volume>114</volume>
            <issue>23</issue>
            <fpage>2534</fpage>
            <page-range>2534-70</page-range>
            <pub-id pub-id-type="pmid">17130345</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Glinge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sattler</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Jabbari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Tfelt-Hansen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology and genetics of ventricular fibrillation during acute myocardial infarction.</article-title>
            <source>J Geriatr Cardiol</source>
            <year>2016</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>9</issue>
            <fpage>789</fpage>
            <page-range>789-797</page-range>
            <pub-id pub-id-type="pmid">27899944</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jabbari</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Engstr&#x000f8;m</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Glinge</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Risgaard</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Jabbari</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Winkel</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Terkelsen</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Tilsted</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Jensen</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Hougaard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chiuve</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Pedersen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Svendsen</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Hauns&#x000f8;</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Albert</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Tfelt-Hansen</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Incidence and risk factors of ventricular fibrillation before primary angioplasty in patients with first ST-elevation myocardial infarction: a nationwide study in Denmark.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2015</year>
            <month>Jan</month>
            <day>05</day>
            <volume>4</volume>
            <issue>1</issue>
            <fpage>e001399</fpage>
            <pub-id pub-id-type="pmid">25559012</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Samie</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Jalife</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Mechanisms underlying ventricular tachycardia and its transition to ventricular fibrillation in the structurally normal heart.</article-title>
            <source>Cardiovasc Res</source>
            <year>2001</year>
            <month>May</month>
            <volume>50</volume>
            <issue>2</issue>
            <fpage>242</fpage>
            <page-range>242-50</page-range>
            <pub-id pub-id-type="pmid">11334828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bezzina</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Pazoki</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Bardai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marsman</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>de Jong</surname>
                <given-names>JSSG</given-names>
              </name>
              <name>
                <surname>Blom</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Scicluna</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Jukema</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Bindraban</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Lichtner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Pfeufer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bishopric</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Roden</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Meitinger</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Chugh</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Myerburg</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Jouven</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>K&#x000e4;&#x000e4;b</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dekker</surname>
                <given-names>LRC</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Tanck</surname>
                <given-names>MWT</given-names>
              </name>
              <name>
                <surname>Wilde</surname>
                <given-names>AAM</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide association study identifies a susceptibility locus at 21q21 for ventricular fibrillation in acute myocardial infarction.</article-title>
            <source>Nat Genet</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>42</volume>
            <issue>8</issue>
            <fpage>688</fpage>
            <page-range>688-691</page-range>
            <pub-id pub-id-type="pmid">20622880</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Adabag</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Luepker</surname>
                <given-names>RV</given-names>
              </name>
              <name>
                <surname>Roger</surname>
                <given-names>VL</given-names>
              </name>
              <name>
                <surname>Gersh</surname>
                <given-names>BJ</given-names>
              </name>
            </person-group>
            <article-title>Sudden cardiac death: epidemiology and risk factors.</article-title>
            <source>Nat Rev Cardiol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>4</issue>
            <fpage>216</fpage>
            <page-range>216-25</page-range>
            <pub-id pub-id-type="pmid">20142817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Al-Khatib</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Stevenson</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Ackerman</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Bryant</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Callans</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Curtis</surname>
                <given-names>AB</given-names>
              </name>
              <name>
                <surname>Deal</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Dickfeld</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Field</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Fonarow</surname>
                <given-names>GC</given-names>
              </name>
              <name>
                <surname>Gillis</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Granger</surname>
                <given-names>CB</given-names>
              </name>
              <name>
                <surname>Hammill</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Hlatky</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Joglar</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Kay</surname>
                <given-names>GN</given-names>
              </name>
              <name>
                <surname>Matlock</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Myerburg</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.</article-title>
            <source>J Am Coll Cardiol</source>
            <year>2018</year>
            <month>Oct</month>
            <day>02</day>
            <volume>72</volume>
            <issue>14</issue>
            <fpage>1677</fpage>
            <page-range>1677-1749</page-range>
            <pub-id pub-id-type="pmid">29097294</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dumas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Cariou</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manzo-Silberman</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Grimaldi</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Vivien</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rosencher</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Empana</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Carli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mira</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Jouven</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Spaulding</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Immediate percutaneous coronary intervention is associated with better survival after out-of-hospital cardiac arrest: insights from the PROCAT (Parisian Region Out of hospital Cardiac ArresT) registry.</article-title>
            <source>Circ Cardiovasc Interv</source>
            <year>2010</year>
            <month>Jun</month>
            <day>01</day>
            <volume>3</volume>
            <issue>3</issue>
            <fpage>200</fpage>
            <page-range>200-7</page-range>
            <pub-id pub-id-type="pmid">20484098</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Honarmand</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Mepham</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Ainsworth</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Khalid</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Adherence to advanced cardiovascular life support (ACLS) guidelines during in-hospital cardiac arrest is associated with improved outcomes.</article-title>
            <source>Resuscitation</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>129</volume>
            <fpage>76</fpage>
            <page-range>76-81</page-range>
            <pub-id pub-id-type="pmid">29885353</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Krumholz</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Nichol</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Nallamothu</surname>
                <given-names>BK</given-names>
              </name>
              <collab>American Heart Association National Registry of Cardiopulmonary Resuscitation Investigators</collab>
            </person-group>
            <article-title>Delayed time to defibrillation after in-hospital cardiac arrest.</article-title>
            <source>N Engl J Med</source>
            <year>2008</year>
            <month>Jan</month>
            <day>03</day>
            <volume>358</volume>
            <issue>1</issue>
            <fpage>9</fpage>
            <page-range>9-17</page-range>
            <pub-id pub-id-type="pmid">18172170</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Laina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Karlis</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Liakos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Georgiopoulos</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Oikonomou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kouskouni</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chalkias</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Xanthos</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Amiodarone and cardiac arrest: Systematic review and meta-analysis.</article-title>
            <source>Int J Cardiol</source>
            <year>2016</year>
            <month>Oct</month>
            <day>15</day>
            <volume>221</volume>
            <fpage>780</fpage>
            <page-range>780-8</page-range>
            <pub-id pub-id-type="pmid">27434349</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bardy</surname>
                <given-names>GH</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Mark</surname>
                <given-names>DB</given-names>
              </name>
              <name>
                <surname>Poole</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Packer</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Boineau</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Domanski</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Troutman</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Anderson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>McNulty</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Clapp-Channing</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Davidson-Ray</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Fraulo</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Fishbein</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Luceri</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ip</surname>
                <given-names>JH</given-names>
              </name>
              <collab>Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators</collab>
            </person-group>
            <article-title>Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.</article-title>
            <source>N Engl J Med</source>
            <year>2005</year>
            <month>Jan</month>
            <day>20</day>
            <volume>352</volume>
            <issue>3</issue>
            <fpage>225</fpage>
            <page-range>225-37</page-range>
            <pub-id pub-id-type="pmid">15659722</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levantesi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Scarano</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Marfisi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Borrelli</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rutjes</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Silletta</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Tognoni</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Marchioli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Meta-analysis of effect of statin treatment on risk of sudden death.</article-title>
            <source>Am J Cardiol</source>
            <year>2007</year>
            <month>Dec</month>
            <day>01</day>
            <volume>100</volume>
            <issue>11</issue>
            <fpage>1644</fpage>
            <page-range>1644-50</page-range>
            <pub-id pub-id-type="pmid">18036362</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Holmberg</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Holmberg</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Herlitz</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Incidence, duration and survival of ventricular fibrillation in out-of-hospital cardiac arrest patients in sweden.</article-title>
            <source>Resuscitation</source>
            <year>2000</year>
            <month>Mar</month>
            <volume>44</volume>
            <issue>1</issue>
            <fpage>7</fpage>
            <page-range>7-17</page-range>
            <pub-id pub-id-type="pmid">10699695</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31086.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Demidova</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>H&#x000f6;ijer</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Holmqvist</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Erlinge</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Platonov</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Prognostic impact of early ventricular fibrillation in patients with ST-elevation myocardial infarction treated with primary PCI.</article-title>
            <source>Eur Heart J Acute Cardiovasc Care</source>
            <year>2012</year>
            <month>Dec</month>
            <volume>1</volume>
            <issue>4</issue>
            <fpage>302</fpage>
            <page-range>302-11</page-range>
            <pub-id pub-id-type="pmid">24062921</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
